DBpedia – Linked Data Fragments

Matches in DBpedia 2016-04 for { ?s ?p "The Designer Anabolic Steroid Control Act of 2014 (H.R. 4771) is a bill that expanded the list of anabolic steroids regulated by the Drug Enforcement Administration (DEA) to include about two dozen new substances and established new crimes relating to false labeling of steroids. This type of steroid enhances muscles. The bill established a penalty of up to $500,000 against those found to be falsely labeling their anabolic steroid products.Specifically, the text of the bill reads: \"In the case of a violation...by an importer, exporter, manufacturer, or distributor...up to $500,000 per violation...For purposes of this subparagraph, a violation is defined as each instance of importation, exportation, manufacturing, distribution, or possession with intent to manufacture or distribute. The bill further reads: \"In the case of a distribution, dispensing, or possession with intent to distribute or dispense in violation of...this section at the retail level, up to $1000 per violation. For purposes of this paragraph, the term at the retail level refers to products sold, or held for sale, directly to the consumer for personal use. Each package, container or other separate unit containing an anabolic steroid that is distributed, dispensed, or possessed with intent to distribute or dispense at the retail level in violation...shall be considered a separate violation. \"The bill was introduced into the United States House of Representatives during the 113th United States Congress. The President signed the bill into law on December 18, 2014."@en }

• Designer_Anabolic_Steroid_Control_Act_of_2014 abstract "The Designer Anabolic Steroid Control Act of 2014 (H.R. 4771) is a bill that expanded the list of anabolic steroids regulated by the Drug Enforcement Administration (DEA) to include about two dozen new substances and established new crimes relating to false labeling of steroids. This type of steroid enhances muscles. The bill established a penalty of up to $500,000 against those found to be falsely labeling their anabolic steroid products.Specifically, the text of the bill reads: \"In the case of a violation...by an importer, exporter, manufacturer, or distributor...up to $500,000 per violation...For purposes of this subparagraph, a violation is defined as each instance of importation, exportation, manufacturing, distribution, or possession with intent to manufacture or distribute. The bill further reads: \"In the case of a distribution, dispensing, or possession with intent to distribute or dispense in violation of...this section at the retail level, up to $1000 per violation. For purposes of this paragraph, the term at the retail level refers to products sold, or held for sale, directly to the consumer for personal use. Each package, container or other separate unit containing an anabolic steroid that is distributed, dispensed, or possessed with intent to distribute or dispense at the retail level in violation...shall be considered a separate violation. \"The bill was introduced into the United States House of Representatives during the 113th United States Congress. The President signed the bill into law on December 18, 2014.".